Xi Zhang

发表

Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target.

Ariel Fernández, Gabriel Lopez-Berestein, Ariel Fernández, 2007, Cancer research.

CHP2 Activates the Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway and Enhances the Oncogenic Potential of HEK293 Cells*

Rong Li, Q. Wei, Ping Liu, 2008, Journal of Biological Chemistry.

identified a series of mutated genes and somatic copy‐number alterations in gynecological cancer by comprehensively analyzing TCGA datasets. Song et al (11) constructed an aberrant long noncoding RNA‐microRNA‐mRNA network in CESC using TCGA datasets. Comprehensive analysis of TCGA datasets provides

Xi Zhang, Yudong Wang, 2019 .

Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women.

U. Stendahl, Xi Zhang, B. Cui, 2009, International journal of oncology.

ID4 Promotes Breast Cancer Chemotherapy Resistance via CBF1-MRP1 Pathway

Yuanyuan Zong, Xi Zhang, Ye-jun Qin, 2020, Journal of Cancer.

DW09849, a Selective Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Prevents PI3K Signaling and Preferentially Inhibits Proliferation of Cells Containing the Oncogenic Mutation p110α (H1047R)

Jian Ding, Lin-jiang Tong, Linghua Meng, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.

Juan Zhou, Xi Zhang, Qiaoting Hu, 2018, Oncology reports.

Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis

S. McColley, Xi Zhang, H. Levy, 2019, Scientific Reports.

DDX21 interacts with nuclear AGO2 and regulates the alternative splicing of SMN2.

Xiang Hu, Yaru Wang, Shuanglin Xiang, 2020, Bioscience, biotechnology, and biochemistry.

Identification of hub genes and key pathways associated with the progression of gynecological cancer

Xi Zhang, Yudong Wang, 2019, Oncology letters.

Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development.

Yu Yu, Junzhou Wu, Lihua Qi, 2018, The international journal of biochemistry & cell biology.

Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer

Juan Zhou, Xi Zhang, Bei Chen, 2015, Oncotarget.

SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.

Xi Zhang, Sitong Zhou, Yanhua Liang, 2020, The Journal of investigative dermatology.

UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways

Xi Zhang, Sitong Zhou, Ronghua Yang, 2021, Cancer Cell International.

MicroRNA‑126‑3p inhibits the proliferation, migration, invasion, and angiogenesis of triple‑negative breast cancer cells by targeting RGS3.

Xi Zhang, Chuanwang Wang, Zhipeng Hong, 2019, Oncology reports.

The EZH2–PHACTR2–AS1–Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer

Wei-Guo Zhu, Yu Yu, Wei Zhao, 2020, Cancer Research.

HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.

Hui Li, Xi Zhang, Xinxing Wang, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next‐Generation Sequencing are associated with disease progression in a North American Adult T‐Cell Leukemia/Lymphoma cohort

R. Naeem, Xi Zhang, Yang Shi, 2021, International journal of laboratory hematology.

Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis

S. McColley, Xi Zhang, H. Levy, 2019, Scientific Reports.